Related Experiment Video
Updated: May 1, 2026

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes
Published on: February 22, 2017
Nuclear trafficking of the HIV-1 pre-integration complex depends on the ADAM10 intracellular domain
Mark A Endsley1, Anoma D Somasunderam1, Guangyu Li2
1Department Internal Medicine, Division of Infectious Diseases, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA.
Abstract:
Previously, we showed that ADAM10 is necessary for HIV-1 replication in primary human macrophages and immortalized cell lines. Silencing ADAM10 expression interrupted the HIV-1 life cycle prior to nuclear translocation of viral cDNA. Furthermore, our data indicated that HIV-1 replication depends on the expression of ADAM15 and γ-secretase, which proteolytically processes ADAM10. Silencing ADAM15 or γ-secretase expression inhibits HIV-1 replication between reverse transcription and nuclear entry. Here, we show that ADAM10 expression also supports replication in CD4(+) T lymphocytes. The intracellular domain (ICD) of ADAM10 associates with the HIV-1 pre-integration complex (PIC) in the cytoplasm and immunoprecipitates and co-localizes with HIV-1 integrase, a key component of PIC. Taken together, our data support a model whereby ADAM15/γ-secretase processing of ADAM10 releases the ICD, which then incorporates into HIV-1 PIC to facilitate nuclear trafficking. Thus, these studies suggest ADAM10 as a novel therapeutic target for inhibiting HIV-1 prior to nuclear entry.
Insights
ADAM10 protein is crucial for HIV-1 replication by aiding viral nuclear entry in T lymphocytes. Inhibiting ADAM10 processing offers a new strategy to block HIV-1 before it reaches the nucleus.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- ADAM10 is essential for HIV-1 replication in macrophages and cell lines.
- HIV-1 replication is interrupted prior to nuclear translocation when ADAM10 is silenced.
- HIV-1 replication also depends on ADAM15 and γ-secretase, which process ADAM10.
Purpose of the Study:
- To investigate the role of ADAM10 in HIV-1 replication in CD4(+) T lymphocytes.
- To elucidate the mechanism by which ADAM10 supports HIV-1 replication.
- To identify ADAM10 as a potential therapeutic target for HIV-1 infection.
Main Methods:
- Silencing gene expression (ADAM10, ADAM15, γ-secretase).
- Studying HIV-1 replication in CD4(+) T lymphocytes.
- Investigating protein interactions using immunoprecipitation and co-localization assays.
Main Results:
- ADAM10 expression supports HIV-1 replication in CD4(+) T lymphocytes.
- The intracellular domain (ICD) of ADAM10 associates with the HIV-1 pre-integration complex (PIC).
- ADAM10 ICD co-localizes with HIV-1 integrase within the PIC in the cytoplasm.
Conclusions:
- ADAM15/γ-secretase processing of ADAM10 releases its ICD.
- The ICD of ADAM10 is incorporated into the HIV-1 PIC, facilitating nuclear trafficking.
- ADAM10 represents a novel therapeutic target for blocking HIV-1 replication prior to nuclear entry.
Related Concept Videos
Nuclear Localization Signals and Import
Regulation of Nuclear Protein Sorting
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Size and Structure of Viral Genomes
Directionality of Nuclear Transport
Protein Transport into the Inner Mitochondrial Membrane
Transport of mitochondrial precursors across the TIM23 channel is driven by...

